These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 38508079)
61. Recent advances and patents on solid lipid nanoparticles. Sawant KK; Dodiya SS Recent Pat Drug Deliv Formul; 2008; 2(2):120-35. PubMed ID: 19075903 [TBL] [Abstract][Full Text] [Related]
62. Solid Lipid Nanoparticles: Applications and Prospects in Cancer Treatment. Sivadasan D; Ramakrishnan K; Mahendran J; Ranganathan H; Karuppaiah A; Rahman H Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047172 [TBL] [Abstract][Full Text] [Related]
63. The improvement of the anticancer effect of a novel compound benzoic acid, 2-hydroxy-, 2-D-ribofuranosylhydrazide (BHR) loaded in solid lipid nanoparticles. Wang M; Qin L; Li K; Zhu R; Wang W; Wang S AAPS PharmSciTech; 2012 Dec; 13(4):1348-54. PubMed ID: 23054988 [TBL] [Abstract][Full Text] [Related]
64. Multivariate Optimization of Rizatriptan Benzoate-Loaded Solid Lipid Nanoparticles for Brain Targeting and Migraine Management. Girotra P; Singh SK AAPS PharmSciTech; 2017 Feb; 18(2):517-528. PubMed ID: 27126007 [TBL] [Abstract][Full Text] [Related]
65. Solid Lipid Nanoparticles for Topical Drug Delivery: Mechanisms, Dosage Form Perspectives, and Translational Status. Liu M; Wen J; Sharma M Curr Pharm Des; 2020; 26(27):3203-3217. PubMed ID: 32452322 [TBL] [Abstract][Full Text] [Related]
67. Perspectives on cutting-edge nanoparticulate drug delivery technologies based on lipids and their applications. Maddiboyina B; Ramaiah ; Nakkala RK; Roy H Chem Biol Drug Des; 2023 Aug; 102(2):377-394. PubMed ID: 36916008 [TBL] [Abstract][Full Text] [Related]
68. Fluconazole-loaded solid lipid nanoparticles topical gel for treatment of pityriasis versicolor: formulation and clinical study. El-Housiny S; Shams Eldeen MA; El-Attar YA; Salem HA; Attia D; Bendas ER; El-Nabarawi MA Drug Deliv; 2018 Nov; 25(1):78-90. PubMed ID: 29239242 [TBL] [Abstract][Full Text] [Related]
69. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs? Das S; Ng WK; Tan RB Eur J Pharm Sci; 2012 Aug; 47(1):139-51. PubMed ID: 22664358 [TBL] [Abstract][Full Text] [Related]
70. Preparation, optimization, and Nasiri F; Faghfouri L; Hamidi M Drug Dev Ind Pharm; 2020 Jan; 46(1):159-171. PubMed ID: 31894713 [No Abstract] [Full Text] [Related]
71. Sulconazole-Loaded Solid Lipid Nanoparticles for Enhanced Antifungal Activity: In Vitro and In Vivo Approach. Samee A; Usman F; Wani TA; Farooq M; Shah HS; Javed I; Ahmad H; Khan R; Zargar S; Kausar S Molecules; 2023 Nov; 28(22):. PubMed ID: 38005230 [TBL] [Abstract][Full Text] [Related]
72. Sodium alginate-based smart gastro-retentive drug delivery system of revaprazan loaded SLNs; Formulation and characterization. Raja HN; Din FU; Shabbir K; Khan S; Alamri AH; Al Awadh AA; Lahiq AA; Alasiri A Int J Biol Macromol; 2023 Dec; 253(Pt 6):127402. PubMed ID: 37832620 [TBL] [Abstract][Full Text] [Related]
73. Formulation, optimization, and characterization of rifampicin-loaded solid lipid nanoparticles for the treatment of tuberculosis. Chokshi NV; Khatri HN; Patel MM Drug Dev Ind Pharm; 2018 Dec; 44(12):1975-1989. PubMed ID: 30058392 [TBL] [Abstract][Full Text] [Related]
74. Preparation, in vitro and in vivo Evaluation of Thermosensitive in situ Gel Loaded with Ibuprofen-Solid Lipid Nanoparticles for Rectal Delivery. Huang CH; Hu PY; Wu QY; Xia MY; Zhang WL; Lei ZQ; Li DX; Zhang GS; Feng JF Drug Des Devel Ther; 2022; 16():1407-1431. PubMed ID: 35586185 [TBL] [Abstract][Full Text] [Related]
76. Preparation, Characterization and Anti-Ulcer Efficacy of Sanguinarine Loaded Solid Lipid Nanoparticles. Sun Q; Li W; Li H; Wang X; Wang Y; Niu X Pharmacology; 2017; 100(1-2):14-24. PubMed ID: 28334726 [TBL] [Abstract][Full Text] [Related]
77. Formulation and Pathohistological Study of Mizolastine-Solid Lipid Nanoparticles-Loaded Ocular Hydrogels. El-Emam GA; Girgis GNS; Hamed MF; El-Azeem Soliman OA; Abd El Gawad AEGH Int J Nanomedicine; 2021; 16():7775-7799. PubMed ID: 34853513 [TBL] [Abstract][Full Text] [Related]
78. Lipid-based carriers: manufacturing and applications for pulmonary route. Jaafar-Maalej C; Elaissari A; Fessi H Expert Opin Drug Deliv; 2012 Sep; 9(9):1111-27. PubMed ID: 22724618 [TBL] [Abstract][Full Text] [Related]
79. Nano-fats for bugs: the benefits of lipid nanoparticles for antimicrobial therapy. Thorn CR; Thomas N; Boyd BJ; Prestidge CA Drug Deliv Transl Res; 2021 Aug; 11(4):1598-1624. PubMed ID: 33675007 [TBL] [Abstract][Full Text] [Related]
80. Characterization and stability of nanostructured lipid carriers as drug delivery system. Abbasalipourkabir R; Salehzadeh A; Abdullah R Pak J Biol Sci; 2012 Feb; 15(3):141-6. PubMed ID: 22866544 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]